@ShahidNShah
Delivering Medical Innovation in a Value-based World
Discover the implications for medical innovation as the health care industry transitions to value-based care. Biopharma, medtech, health plans, and provider executives suggest four changes that could encourage innovation as value-based care takes root and evolves. The Deloitte Center for Health Solutions and the Network for Excellence in Health Innovation (NEHI) convened 21 leaders across the health care system including life sciences companies, health plans, providers, academics, non-profits, and patient groups in fall 2015 to discuss how VBC influences innovation, how current VBC models could evolve to encourage innovation, and the strategic considerations for biopharma and medical technology (medtech) companies. Meeting participants pointed out that ongoing cross-stakeholder dialogue is critical to ensure that valuable medical innovations continue to reach patients as VBC models take root and evolve.
Continue reading at 2.deloitte.com
Make faster decisions with community advice
- HealthLeaders Podcast: Bowden Eye & Associates
- How Transcarent Is Expanding Access to Expert Second Opinions
- "The Third Leg": Examining the Market for Conversational Technologies
- Caregiver Proxy Patient Portal Access Leaves Much to Be Desired
- HHS announces test-to-treat telehealth pilot for COVID-19
Next Article
-
Tapping your ERP for healthcare supply chain resiliency
The healthcare supply chain is under enormous pressure. Ongoing disruptions and workforce challenges have supply chain teams dealing with product shortages and chasing backorders. Add to this …